Lexicon Pharma (LXRX) Misses Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts LXRX Hot Sheet
Price: $2.37 +1.28%
Financial Fact:
Subscription and license fees: 31K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Subscription and license fees: 31K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q1 EPS of ($0.34), $0.04 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $12.5 million versus the consensus estimate of $11.11 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- The free USDA tool that tracks egg prices at $0.62/dozen before your data vendor does
- Nvidia and Broadcom earnings: TD Cowen says earnings won’t settle big questions
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
